Evidence map›Paper›PMID 38393374›Full record

GuidelineEuropean journal of nuclear medicine and molecular imaging2024

EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy.

Tatjana Traub-Weidinger, Javier Arbizu, Henryk Barthel, Ronald Boellaard, Lise Borgwardt, Matthias Brendel, Diego Cecchin, Francine Chassoux, Francesco Fraioli, Valentina Garibotto and 11 more

Open access · hybridAbstract readPractice Guideline
In one paragraph

Guideline in European journal of nuclear medicine and molecular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
16.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Detection of Focal Lesions in Epilepsy with [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  5. Article
  6. [BMC neurology · 2026
    Article
  7. Review
  8. Head to head comparison between arterial spin labelling MRI and [Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Observational
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Seminars in epileptology: Presurgical epilepsy evaluation.Epileptic disorders : international epilepsy journal with videotape · 2025
    Review
  15. Article
  16. Article
  17. Observational
  18. Review
  19. BrainEpilepsia · 2025
    Article
  20. Quantitative Cortex-Based Mapping With HybridCNS neuroscience & therapeutics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 17 institutions in 10 countries.

Tatjana Traub-WeidingerDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
Javier ArbizuDepartment of Nuclear Medicine, University of Navarra Clinic, Pamplona, Spain.
Henryk BarthelDepartment of Nuclear Medicine, Leipzig University Medical Centre, Leipzig, Germany.
Ronald BoellaardDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands.
Lise BorgwardtDepartment of Clinical Physiology and Nuclear Medicine, University of Copenhagen, Blegdamsvej 9, DK-2100, RigshospitaletCopenhagen, Denmark.
Matthias BrendelDepartment of Nuclear Medicine, Ludwig Maximilian-University of Munich, Munich, Germany.
Diego CecchinNuclear Medicine Unit, Department of Medicine-DIMED, University-Hospital of Padova, Padova, Italy.
Francine ChassouxUniversité Paris-Saclay, CEA, CNRS, Inserm, BioMaps, 91401, Orsay, France.
Francesco FraioliInstitute of Nuclear Medicine, University College London (UCL), London, UK.
Valentina GaribottoDivision of Nuclear Medicine and Molecular Imaging, Geneva University Hospitals, Geneva, Switzerland.
Eric GuedjAPHM, CNRS, Centrale Marseille, Institut Fresnel, Timone Hospital, CERIMED, Nuclear Medicine Department, Aix Marseille Univ, Marseille, France.
Alexander HammersSchool of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London & Guy's and St Thomas' PET Centre, King's College London, London, UK.
Ian LawDepartment of Clinical Physiology and Nuclear Medicine, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.
Silvia MorbelliNuclear Medicine Unit, IRCCS Ospedale Policlinico San Martino, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
Nelleke TolboomDepartment of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Donatienne Van WeehaegheDepartment of Radiology and Nuclear Medicine, Ghent University Hospital, Ghent, Belgium.
Antoine VergerDepartment of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, IADI, INSERM U1254, Nancy, France.
Wim Van PaesschenLaboratory for Epilepsy Research, KU Leuven and Department of Neurology, University Hospitals, Leuven, Belgium.
Tim J von OertzenDepts of Neurology 1&2, Kepler University Hospital, Johannes Kepler University, Linz, Austria.
Pietro ZucchettaNuclear Medicine Unit, Department of Medicine-DIMED, University-Hospital of Padova, Padova, Italy.
Franck SemahNuclear Medicine Department, University Hospital, Inserm, CHU Lille, U1172-LilNCog-Lille, F-59000, Lille, France. franck.semah@chu-lille.fr.ORCID 0000-0002-9190-1116
Centre National de la Recherche Scientifique · FRInserm · FRUniversity of Copenhagen · DKUniversity of Padua · ITAmsterdam University Medical Centers · NLGerman Center for Neurodegenerative Diseases · DEGhent University Hospital · BEJohannes Kepler University of Linz · ATKing's College London · GBKU Leuven · BELeipzig University · DEMedical University of Vienna · ATOspedale Policlinico San Martino · ITUniversidad de Navarra · ESUniversity College London · GBUniversity of Geneva · CHUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epilepsy is one of the most frequent neurological conditions with an estimated prevalence of more than 50 million people worldwide and an annual incidence of two million. Although pharmacotherapy with anti-seizure medication (ASM) is the treatment of choice, ~30% of patients with epilepsy do not respond to ASM and become drug resistant. Focal epilepsy is the most frequent form of epilepsy. In patients with drug-resistant focal epilepsy, epilepsy surgery is a treatment option depending on the localisation of the seizure focus for seizure relief or seizure freedom with consecutive improvement in quality of life. Beside examinations such as scalp video/electroencephalography (EEG) telemetry, structural, and functional magnetic resonance imaging (MRI), which are primary standard tools for the diagnostic work-up and therapy management of epilepsy patients, molecular neuroimaging using different radiopharmaceuticals with single-photon emission computed tomography (SPECT) and positron emission tomography (PET) influences and impacts on therapy decisions. To date, there are no literature-based praxis recommendations for the use of Nuclear Medicine (NM) imaging procedures in epilepsy. The aims of these guidelines are to assist in understanding the role and challenges of radiotracer imaging for epilepsy; to provide practical information for performing different molecular imaging procedures for epilepsy; and to provide an algorithm for selecting the most appropriate imaging procedures in specific clinical situations based on current literature. These guidelines are written and authorized by the European Association of Nuclear Medicine (EANM) to promote optimal epilepsy imaging, especially in the presurgical setting in children, adolescents, and adults with focal epilepsy. They will assist NM healthcare professionals and also specialists such as Neurologists, Neurophysiologists, Neurosurgeons, Psychiatrists, Psychologists, and others involved in epilepsy management in the detection and interpretation of epileptic seizure onset zone (SOZ) for further treatment decision. The information provided should be applied according to local laws and regulations as well as the availability of various radiopharmaceuticals and imaging modalities.

Indexed as

EpilepsyPositron-Emission TomographyTomography, Emission-Computed, Single-PhotonEuropeHumansNuclear Medicine[18F]FDG PETDrug-resistant epilepsyExtratemporal epilepsyFocal epilepsyIctal SPECTImagingInterictal SPECTMRINeurotransmitter PETPaediatric epileptic syndromesPresurgical evaluationSurgeryTemporal lobe epilepsy

Identifiers

PMID38393374
PMCPMC11139752
OpenAlexW4392096669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.